These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17261171)

  • 1. Antibody-mediated delivery of IL-10 inhibits the progression of established collagen-induced arthritis.
    Trachsel E; Bootz F; Silacci M; Kaspar M; Kosmehl H; Neri D
    Arthritis Res Ther; 2007; 9(1):R9. PubMed ID: 17261171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antibody-mediated targeted delivery of interleukin-15 and GM-CSF to the tumor neovasculature inhibits tumor growth and metastasis.
    Kaspar M; Trachsel E; Neri D
    Cancer Res; 2007 May; 67(10):4940-8. PubMed ID: 17510424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune modulation of collagen-induced arthritis by intranasal cytokine gene delivery: a model for the therapy of rheumatoid arthritis.
    Woods AM; Thompson SJ; Wooley PH; Panayi G; Klavinskis LS
    Arthritis Rheum; 2005 Dec; 52(12):3761-71. PubMed ID: 16329091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The targeted immunocytokine L19-IL2 efficiently inhibits the growth of orthotopic pancreatic cancer.
    Wagner K; Schulz P; Scholz A; Wiedenmann B; Menrad A
    Clin Cancer Res; 2008 Aug; 14(15):4951-60. PubMed ID: 18676770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis.
    Schwager K; Kaspar M; Bootz F; Marcolongo R; Paresce E; Neri D; Trachsel E
    Arthritis Res Ther; 2009; 11(5):R142. PubMed ID: 19781067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphoteric liposomes enable systemic antigen-presenting cell-directed delivery of CD40 antisense and are therapeutically effective in experimental arthritis.
    Andreakos E; Rauchhaus U; Stavropoulos A; Endert G; Wendisch V; Benahmed AS; Giaglis S; Karras J; Lee S; Gaus H; Bennett CF; Williams RO; Sideras P; Panzner S
    Arthritis Rheum; 2009 Apr; 60(4):994-1005. PubMed ID: 19333921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the interleukin-21/interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis.
    Young DA; Hegen M; Ma HL; Whitters MJ; Albert LM; Lowe L; Senices M; Wu PW; Sibley B; Leathurby Y; Brown TP; Nickerson-Nutter C; Keith JC; Collins M
    Arthritis Rheum; 2007 Apr; 56(4):1152-63. PubMed ID: 17393408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Localized expression of an anti-TNF single-chain antibody prevents development of collagen-induced arthritis.
    Smith R; Tarner IH; Hollenhorst M; Lin C; Levicnik AU; Fathman CG; Nolan GP
    Gene Ther; 2003 Aug; 10(15):1248-57. PubMed ID: 12858190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on intra-articular versus systemic gene electrotransfer in experimental arthritis.
    Khoury M; Bigey P; Louis-Plence P; Noel D; Rhinn H; Scherman D; Jorgensen C; Apparailly F
    J Gene Med; 2006 Aug; 8(8):1027-36. PubMed ID: 16733831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.
    Plater-Zyberk C; Joosten LA; Helsen MM; Sattonnet-Roche P; Siegfried C; Alouani S; van De Loo FA; Graber P; Aloni S; Cirillo R; Lubberts E; Dinarello CA; van Den Berg WB; Chvatchko Y
    J Clin Invest; 2001 Dec; 108(12):1825-32. PubMed ID: 11748266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined blockade of granulocyte-macrophage colony stimulating factor and interleukin 17 pathways potently suppresses chronic destructive arthritis in a tumour necrosis factor alpha-independent mouse model.
    Plater-Zyberk C; Joosten LA; Helsen MM; Koenders MI; Baeuerle PA; van den Berg WB
    Ann Rheum Dis; 2009 May; 68(5):721-8. PubMed ID: 18495731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
    Spohn G; Keller I; Beck M; Grest P; Jennings GT; Bachmann MF
    Eur J Immunol; 2008 Mar; 38(3):877-87. PubMed ID: 18253928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes.
    Khoury M; Escriou V; Courties G; Galy A; Yao R; Largeau C; Scherman D; Jorgensen C; Apparailly F
    Arthritis Rheum; 2008 Aug; 58(8):2356-67. PubMed ID: 18668557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 reduces the severity of collagen-induced arthritis.
    Tanaka K; Horikawa T; Suzuki S; Kitaura K; Watanabe J; Gotoh A; Shiobara N; Itoh T; Yamane S; Suzuki R; Fukui N; Ochi T
    J Rheumatol; 2008 Dec; 35(12):2316-24. PubMed ID: 19004048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice.
    Li H; Gong X; Zhang L; Zhang Z; Luo F; Zhou Q; Chen J; Wan J
    Phytomedicine; 2009 Jun; 16(6-7):538-46. PubMed ID: 19135346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
    Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
    Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive role of leukocyte cell-derived chemotaxin 2 in mouse anti-type II collagen antibody-induced arthritis.
    Okumura A; Saito T; Otani I; Kojima K; Yamada Y; Ishida-Okawara A; Nakazato K; Asano M; Kanayama K; Iwakura Y; Suzuki K; Yamagoe S
    Arthritis Rheum; 2008 Feb; 58(2):413-21. PubMed ID: 18240267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.